EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY 4.0

IL-24 in COVID-19 Patients: Correlations with Disease Progression

Richard Vollenberg, Katharina Schütte-Nütgen, Markus Strauss, Jonel Trebicka, Julia Fischer, Phil-Robin Tepasse iD

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms26178403 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Richard Vollenberg und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine B for Gastroenterology, Hepatology, Endocrinology and Clinical Infectiology, University Hospital Muenster, 48149 Muenster, Ger…. Hauptthemen laut MEDLINE: Interleukins, COVID-19. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Innovative Medizinische Forschung (IMF), Medizinische Fakultät, Westfälische Wilhelms-Universität Münster, Germany, Open Access Publication Fund of the University of Muenster.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Interleukin-24 (IL-24) is a cytokine known for its role in immune regulation and apoptosis, with potential implications in viral infections like COVID-19. This study aimed to investigate the association between IL-24 serum levels and the severity of COVID-19 disease. In this prospective bi-center cross-sectional study, we enrolled 41 COVID-19 patients from two hospitals in Germany. Serial blood samples were collected from a subset of patients, resulting in 88 total blood samples. Patients were categorized into critical, severe, moderate, and mild disease groups based on WHO criteria. IL-24 serum levels were measured during the acute or convalescent phase using an ELISA assay. Inflammatory markers, and kidney and liver function parameters were also evaluated. Statistical analysis included non-parametric tests and correlation analysis. Elevated IL-24 serum levels were observed in ambulant patients (mild disease), compared to hospitalized patients (critical, severe, moderate disease, p < 0.05). IL-24 levels were also significantly higher in patients without oxygenation disorder compared to those with oxygenation therapy (p < 0.05). A negative correlation was found between IL-24 levels and markers of inflammation and liver/kidney function. Elevated IL-24 serum levels were associated with milder COVID-19 courses, suggesting a protective role in modulating immune responses and promoting antiviral apoptosis. Conversely, reduced IL-24 in severe cases may reflect impaired immune regulation, highlighting its potential as a biomarker and therapeutic target.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

InterleukinsCOVID-19HumansMaleFemaleMiddle AgedAgedCross-Sectional StudiesDisease ProgressionBiomarkersSARS-CoV-2Prospective StudiesAdultSeverity of Illness IndexGermanyInterleukin-24

Stichwörter der Autor:innen

COVID-19acute respiratory distress syndrome (ARDS)apoptosisbiomarkercytokinesdisease severityimmune responseinflammatory markersinterleukin-24 (IL-24)viral infections

Substanzen

InterleukinsBiomarkersInterleukin-24

Autor:innen und Institutionen

  • Department of Medicine B for Gastroenterology, Hepatology, Endocrinology and Clinical Infectiology, University Hospital Muenster, 48149 Muenster, Germany.
  • Department of Medicine D, Division of General Internal Medicine, Nephrology and Rheumatology, University Hospital of Münster, 48149 Muenster, Germany.
  • Department of Cardiology, Faculty of Health, School of Medicine, University of Witten/Herdecke, 58455 Witten, Germany.
  • Department of Cardiology I-Coronary and Peripheral Vascular Disease, Heart Failure Medicine, University Hospital Muenster, 48149 Muenster, Germany.

ORCID-Profile: Phil-Robin Tepasse

Förderung

  • Innovative Medizinische Forschung (IMF), Medizinische Fakultät, Westfälische Wilhelms-Universität Münster, Germany
  • Open Access Publication Fund of the University of Muenster

Zitieren

APA

Vollenberg, R., Schütte-Nütgen, K., Strauss, M., Trebicka, J., Fischer, J., & Tepasse, P. R. (2025). IL-24 in COVID-19 Patients: Correlations with Disease Progression. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26178403

Vancouver

Vollenberg R, Schütte-Nütgen K, Strauss M, Trebicka J, Fischer J, Tepasse PR. IL-24 in COVID-19 Patients: Correlations with Disease Progression. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26178403

BibTeX
@article{Vollenberg2025,
  author = {Vollenberg, Richard and Schütte-Nütgen, Katharina and Strauss, Markus and Trebicka, Jonel and Fischer, Julia and Tepasse, Phil-Robin},
  title = {IL-24 in COVID-19 Patients: Correlations with Disease Progression},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms26178403}
}
Kostenlos starten →